Association of facial paralysis with mRNA COVID-19 vaccines

SARS-CoV-2 vaccines

During the phase 3 clinical trials of mRNA COVID-19 vaccines, several cases of facial paralysis were observed in the vaccine groups (7 of 35.654) compared with 1 case of 35.611 people who received placebo. This potential safety signal was explored using the WHO pharmacovigilance database, VigiBase. On March 9, 2021, among the 133.883 cases of adverse drug reactions reported following mRNA COVID-19 vaccines a total of 844 facial paralysis-related events were [...]

Create an account and
get free access to full portal features

Choose an option to sign up

Register with Facebook Register with Google Register with your email

The portal

Our goal is to keep you informed on COVID-19 with only the most accurate, fact-check news.

Support our Foundation and work on the #COVID-ACTION project.

DONATE NOW